On the Drug and Biotech Frontier
Guests: Herman Saftlas, Standard & Poor's investment officer, and Frank DiLorenzo, S&P analyst
Explore the market for stocks of pharmaceutical and biotech companies with two Standard & Poor's experts. Find out what names hold the most promise for your portfolio, in another of the chats presented every Tuesday at the same time by BusinessWeek Online and S&P.
Our guests are S&P investment officer Herman Saftlas. He has more than 30 years of experience tracking stocks for S&P -- and has been checking out the pharmas for 15 years. He's a graduate of Queens College in New York City.
Analyst Frank DiLorenzo has been covering the exciting biotech area for two years at S&P. Previously, he was a fixed-income analyst for MetLife. He holds an MBA from Rutgers.
The moderator of this chat with Herman and Frank will be Jack Dierdorff (JackBW), consulting editor of BusinessWeek Online and former managing editor of the magazine. Get your questions ready!